Healthpeak Properties, Inc. $DOC Shares Purchased by Allianz Asset Management GmbH

Key Points

• Allianz Asset Management increased its Healthpeak Properties stake by 21.4% in the second quarter, purchasing 288,905 additional shares and bringing its holdings to 1.64 million shares worth approximately $35.1 million. Institutional investors collectively own 93.57% of the company.
• Analysts maintain a generally cautious outlook, with an average rating of “Hold” and a consensus price target of $21.72. Recent target prices range from $21 to $24.
• Healthpeak exceeded quarterly expectations, reporting $0.08 in EPS versus a $0.03 consensus estimate and $771.6 million in revenue. The REIT also declared a monthly dividend of $0.1017 per share, representing a stated 5.9% annualized yield.

Allianz Asset Management GmbH increased its stake in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 21.4% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,639,312 shares of the real estate investment trust's stock after purchasing an additional 288,905 shares during the quarter. Allianz Asset Management GmbH owned 0.24% of Healthpeak Properties worth $35,081,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Advocate Investing Services LLC purchased a new position in Healthpeak Properties during the 4th quarter worth $26,000. Clearstead Trust LLC boosted its holdings in shares of Healthpeak Properties by 66.7% in the second quarter. Clearstead Trust LLC now owns 1,357 shares of the real estate investment trust's stock valued at $29,000 after acquiring an additional 543 shares in the last quarter. Elyxium Wealth LLC purchased a new stake in shares of Healthpeak Properties in the fourth quarter valued at about $31,000. Clearstead Advisors LLC increased its stake in shares of Healthpeak Properties by 166.3% during the fourth quarter. Clearstead Advisors LLC now owns 1,947 shares of the real estate investment trust's stock worth $31,000 after acquiring an additional 1,216 shares during the period. Finally, CYBER HORNET ETFs LLC acquired a new position in shares of Healthpeak Properties during the second quarter worth about $33,000. 93.57% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

DOC has been the subject of several analyst reports. Morgan Stanley reissued an "equal weight" rating and set a $22.00 price target (up from $20.00) on shares of Healthpeak Properties in a report on Thursday, June 11th. Barclays boosted their target price on Healthpeak Properties from $23.00 to $24.00 and gave the stock an "equal weight" rating in a research report on Monday, August 31st. Wells Fargo & Company increased their target price on Healthpeak Properties from $20.00 to $22.00 and gave the stock an "equal weight" rating in a research note on Wednesday, July 15th. Raymond James Financial assumed coverage on Healthpeak Properties in a research note on Wednesday, June 17th. They set a "market perform" rating for the company. Finally, Evercore downgraded Healthpeak Properties from an "outperform" rating to an "in-line" rating and set a $21.00 price target on the stock. in a research note on Monday, May 11th. Four equities research analysts have rated the stock with a Buy rating and fourteen have given a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus price target of $21.72.

Healthpeak Properties Price Performance

Healthpeak Properties stock opened at $20.65 on Tuesday. Healthpeak Properties, Inc. has a fifty-two week low of $15.70 and a fifty-two week high of $22.95. The firm has a market capitalization of $14.24 billion, a price-to-earnings ratio of 59.00, a price-to-earnings-growth ratio of 2.55 and a beta of 1.01. The stock's fifty day moving average is $21.53 and its two-hundred day moving average is $19.37. The company has a debt-to-equity ratio of 1.06, a quick ratio of 3.02 and a current ratio of 3.02.

Healthpeak Properties (NYSE:DOC - Get Free Report) last announced its quarterly earnings results on Tuesday, August 4th. The real estate investment trust reported $0.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.03 by $0.05. The company had revenue of $771.58 million for the quarter, compared to the consensus estimate of $725.64 million. Healthpeak Properties had a net margin of 8.24% and a return on equity of 2.79%. The company's revenue for the quarter was up 11.1% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.46 earnings per share. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. Analysts predict that Healthpeak Properties, Inc. will post 1.77 EPS for the current fiscal year.

Healthpeak Properties Dividend Announcement

The company also recently declared a monthly dividend, which will be paid on Friday, September 25th. Stockholders of record on Monday, September 14th will be issued a dividend of $0.1017 per share. The ex-dividend date is Monday, September 14th. This represents a c) dividend on an annualized basis and a dividend yield of 5.9%. Healthpeak Properties's payout ratio is 348.57%.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.